一 | 中新网沈阳8月25日电(记者 王景巍)8月25日，辽宁省政府新闻办召开贯彻实施行政复议法有关情况新闻发布会。 Sputnik spoke with Dr. D. B. Bhaaskara, CEO of the multinational company Roerich Healthcare, about the current state of pharma trade with Russia.,Sputnik: Can you explain the current state of pharma supplies to Russia?,D. B. Bhaaskara: Currently, pharmaceutical shipments of Indian firms to Russia are at the same level even after the sanctions. But, there are many proposals (supplies) that Russians are not getting from the European Union. Russians are looking for these materials (chemicals, excipients, APIs [Active Pharmaceutical Ingredients]) with several Indian manufacturers. They have to develop links with Indian firms. There are many proposals from Russia - these proposals are under consideration from the Indian side.,Sputnik: There were reports of delayed payments from Russia initially after sanctions. As we see, trade has jumped manifold in the energy and fertilizer sectors. Do you think payment issues have been resolved in other sectors as well?,D. B. Bhaaskara: Several Indian companies have signed contracts in yuan, which means they are ready to receive payment in China's yuan. Still, the preferred mode of settlement is in the Indian rupee. As export procedures closed successfully in USD/euro/INR, Russians set aside yuan contracts.,My company is receiving regular payment without any delay in Indian rupees or USD or sometimes in euros.,Sputnik: What about logistical issues, as sanctions hit the shipping sector?,D. B. Bhaaskara: The logistical issues are still there because few airlines — namely Aeroflot, Emirates, Qatar, and Turkish — are available for transportation. Transportation costs are slightly high because of no regular cargo consignments. They vary between $8-12 per kg compared to $5 per kg in a normal situation.,Cargo sea shipment is still in a mess. The only port in Gujarat accepts Russian shipping. Here again, the container price is very, very high. We have to pay anything between $9,000 - 12,000 for a container. When there was no conflict or sanctions, it was $2,500 per container.,We have tried to send our shipments via Iran. So, from Gujarat port, the shipment reaches an Iranian port, and from there, it goes via road or rail to Moscow. But, it is taking a much longer time. In general, it is supposed to arrive in 30-40 days, but on an experimental basis, some companies sent their materials via the Iran route, [and they are] still on their way even after two months.,Shanghai is very crowded and has also been hit by the pandemic, making it unsuitable for us. So, the only problem right now is logistics; there is no payment issue.,Some Russian companies have an account with European banks operating in Russia dealing in oil and gas payments. Those banks are being used to send money anywhere worldwide, even with sanctions.,Sputnik: Western firms intended to withdraw their operations in Russia in response to Moscow's special military operation. Do you see some significant investments from Indian pharma companies in Russia to fill the vacuum created by the west?,D. B. Bhaaskara: There are long-pending proposals from a couple of governors, such as [in] Volgograd and Kazan, inviting India's major pharma companies to set up manufacturing units in their region. But, due to the pandemic, nothing moved ahead.,A delegation will be going to Russia to explore the opportunities in Russia in July. A few Indian companies, such as Sun Pharma and Advance Pharma, have manufacturing units in Russia doing finished formulations.,Hopefully, some new companies are interested in setting up units there now. But, Russia is looking to scale up raw material manufacturing, e.g., API. For this, much homework related to regulation should be done between the two governments, especially under sanctions.,Also, big companies such as Sun Pharma, Aurbindo, and Dr. Reddy, all with significant exposure to the US market, may try to avoid investing in Russia because they are scared of the risk associated with sanctions.,Medium-scale companies can come forward to set up raw material (API) manufacturing in Russia. However, it is unclear whether Indian workers/professionals can go and work in Russia. Setting up a new unit in unknown topography with a different language and culture is a little complicated. A lot of these questions are unanswered.。会上，辽宁省司法厅副厅长李郊介绍，自2024年1月1日新修订的行政复议法正式实施以来，辽宁省累计新收行政复议案件7.2万余件，行政复议化解行政争议主渠道作用不断显现。其中，2025年新收3.3万余件，为2023年的2.5倍；2026年上半年新收1.5万余件，为2023年同期的2.2倍。
二 | 据悉，在主动服务发展大局方面，辽宁省着力优化营商环境，新收涉企行政复议案件3240件，累计为企业挽回经济损失约26亿元。
三 | 依托基层司法所设置行政复议代办点416个，在市场主体密集区设立涉企行政复议服务点294个，开通涉企案件“绿色通道”。在民生权益保障领域，辽宁省依法审查社保、医疗、食品安全等重点民生领域案件6221件，直接纠错1951件。 在提质增效方面，辽宁省大力推行“繁简分流”办案机制，40%的案件通过简易程序审理，实现“简案快审、繁案精审”。
四 | 辽宁省依法组织听证案件880件，咨询行政复议委员会专家意见近500件，实现从“书面审理”到“开门办案”的转变。 在实质性化解行政争议方面，辽宁省各级行政复议机构推行案前、案中、案后全流程调解，累计调解和解案件15032件，调撤率达26.4%。沈阳市试点推行“复调对接”模式，依托人民调解设立行政复议调解中心，邀请人民调解员参与复议调解。 在强化监督刚性方面，辽宁省通过变更、撤销、确认违法、责令履行等方式累计纠正案件8378件。针对办案中发现的普遍性问题，累计制发行政复议意见书、建议书924份，其中2025年制发的数量是新修订行政复议法实施前的近10倍，推动从个案纠错到类案规范再到系统治理。 李郊表示，在下步工作中，辽宁省各级行政复议机构将以完善行政复议制度机制为主线，以“提质增效”和“强基固本”为着力点，在“为民护企”“实质解纷”“以案促治”上下功夫，持续发挥行政复议化解行政争议主渠道作用，为辽宁振兴发展提供坚实法治保障。(完) 【编辑:何颖】。
Current article:http://562.cuntoujuefourantapai.cfd/2re2g/qz7.html
Published on:14:00:53
